VolitionRx Initiates Second Prostate Cancer Pilot Study Assessing Nucleosomics(R) Technology
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- S&P 500, Nasdaq set for higher open as SK Hynix lifts chips; Fed in focus
- SK Hynix shares surge after Q3 profit beats expectations
- Oil up 1% as Saudi Arabian refinery attack reignites supply concerns
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
| VolitionRX Limited (NYSE: VNRX) | Delayed: 0.19 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.19 | 52 Week High | $5.86 | |||
| Open | $0.19 | 52 Week Low | $3.05 | |||
| Day High | $0.19 | P/E | N/A | |||
| Day Low | $0.19 | EPS | $-0.45 | |||
| Volume | 329,735 | |||||
| VolitionRX Limited (NYSE: VNRX) | Delayed: 0.19 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.19 | 52 Week High | $5.86 | |||
| Open | $0.19 | 52 Week Low | $3.05 | |||
| Day High | $0.19 | P/E | N/A | |||
| Day Low | $0.19 | EPS | $-0.45 | |||
| Volume | 329,735 | |||||
